Drug Development Technology is using cookies

We use them to give you the best experience. If you continue using our website, we'll assume that you are happy to receive all cookies on this website.

ContinueLearn More X

DelMar Pharma begins dosing in Phase II trial of VAL-083 to treat GBM

Go Top